News Feed - US

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Mar 28, 2024 08:15 ET
Abu Dhabi's Inaugural Autonomous Car Race Series Revolutionizes Fan Experience with Vislink and Focal Point VR
Abu Dhabi is set to become the epicenter of a technological revolution in motorsport entertainment as the A2RL (Abu Dhabi Autonomous Racing League) series, powered by an innovative partnership between Vislink Technologies, Inc. and Focal Point VR...
Mar 28, 2024 08:15 ET
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from...
Mar 28, 2024 08:15 ET
Regency Centers Invites You to Join Its First Quarter 2024 Earnings Conference Call
Regency Centers Corporation (“Regency Centers” or the “Company”) (NASDAQ: REG) will announce its First Quarter 2024 earnings results on Thursday, May 2, 2024, after the market closes. The Company’s earnings release and supplemental information...
Mar 28, 2024 08:11 ET
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, known as engineered toxin bodies, to...
Mar 28, 2024 08:05 ET
Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today reported financial results for the fourth...
Mar 28, 2024 08:05 ET
Applied Digital Sets Fiscal Third Quarter 2024 Earnings Conference Call for Wednesday, April 10, 2024 at 9:00 a.m. Eastern Time
Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder and operator of next-generation digital infrastructure designed for High-Performance Computing (“HPC”) applications, will host a conference call on...
Mar 28, 2024 08:05 ET
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare company, today reported financial results for the three and twelve months ended December 31, 2023 and provided a corporate update. “2023 was a year for Agile that we believe demonstrated...
Mar 28, 2024 08:05 ET
AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM ImmunoTech, will present at the MedInvest Biotech & Pharma Investor Conference being held in New York,...
Mar 28, 2024 08:05 ET
Fresh Del Monte Named One of America’s Most Trusted Companies by Newsweek for the Third Consecutive Year
Fresh Del Monte Produce Inc. (NYSE: FDP), one of the world’s leading vertically integrated producers, distributors, and marketers of fresh and fresh-cut fruits and vegetables, has been named
Mar 28, 2024 08:05 ET
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price
Tevogen Bio Holdings ('Tevogen Bio') (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology, oncology, and neurology, has entered into a securities...
Mar 28, 2024 08:05 ET
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price
Tevogen Bio Holdings ('Tevogen Bio') (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology, oncology, and neurology, has entered into a securities...
Mar 28, 2024 08:03 ET
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and...
Mar 28, 2024 08:03 ET
EXL hosts virtual data and AI event
EXL [NASDAQ: EXLS], a leading data analytics, digital operations, and solutions company, announced its upcoming data and AI virtual event, AI in Action, scheduled for April 24 from 10:00 a.m. to 12:00 p.m. ET. The event promises to be an immersive...
Mar 28, 2024 08:03 ET
Microchip Technology Expands Its Serial SRAM Portfolio to Larger Densities and Increased Speeds
To address a common customer need for bigger and faster SRAM, Microchip Technology (Nasdaq: MCHP) has expanded its Serial SRAM product line to include larger densities of up to 4 Mb and increased Serial Peripheral Interface/Serial Quad I/O™...
Mar 28, 2024 08:01 ET
Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy f
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research scientists, today congratulates its JV partner Virion Therapeutics, LLC, a clinical-stage biotechnology...
Mar 28, 2024 08:01 ET
Xometry Introduces Enhanced Teamspace Collaboration Features To Further Expedite Order Management On Its AI-Powered Marketplace
Xometry Inc. (NASDAQ: XMTR), the global AI-powered marketplace connecting enterprise buyers with suppliers of manufacturing services, today introduced enhanced features for its Teamspace enterprise collaboration software designed to further...
Mar 28, 2024 08:00 ET
Lowell Farms Inc. Announces Audited Fourth Quarter and Fiscal Year 2023 Financial and Operational Results
Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis company with advanced distribution and production capabilities including extraction, manufacturing, sales and brand management, announces audited revenue and...
Mar 28, 2024 08:00 ET
4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis
4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, today announced an update on its...
Mar 28, 2024 08:00 ET
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each...
Mar 28, 2024 08:00 ET
Agrify Corporation Announces Turnkey Hydrocarbon Extraction Equipment Contract with Connecticut-Based Company New England Edibles, dba SoundView
Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced the signing of a Turnkey Hydrocarbon Extraction and Lab Equipment...
Mar 28, 2024 08:00 ET
Akanda Corp. Announces Strategic Plan to Evaluate and Enter Bitcoin, Blockchain, AI Segments of the Cannabis Market
London, United Kingdom--(Newsfile Corp. - March 28, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, announced aspirations to enter technology segments of the cannabis industry. The Company is evaluating potential opportunities to enter Bitcoin, Blockchain, and AI applications in the cannabis industry.
Mar 28, 2024 08:00 ET
Announcement Regarding Possible Offer
The Board of MariaDB plc (NYSE: MRDB) (“MariaDB” or the “Company”) confirms that on March 26, 2024, it received an unsolicited non-binding indicative proposal from Progress Software Corp. (“Progress”) to acquire the entire issued and to be issued share capital of the Company (the “Possible Offer”). Progress provides software that enables organizations to develop and deploy their mission-critical applications and experiences, as well as effectively manage their data platforms, cloud and IT infrastructure. Progress publicly announced such offer on March 26, 2024. The
Mar 28, 2024 08:00 ET
Aqua Metals Announces Participation in Upcoming Investor Conferences
Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium-ion battery recycling, today announced that Steve Cotton, President & Chief Executive Officer, and Judd Merrill, Chief Financial Officer, will participate in the following investor...
Mar 28, 2024 08:00 ET
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the 23rd Annual Needham...
Mar 28, 2024 08:00 ET
Are You AI-Ready? Cisco Networking Academy Is Closing the Gender Gap in AI
NORTHAMPTON, MA / ACCESSWIRE / March 28, 2024 / Cisco Systems Inc.
Mar 28, 2024 08:00 ET
BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis
BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced positive results in a recently published post-marketing study of its...
Mar 28, 2024 08:00 ET
Breckenridge Brewery Announces Special Denver Nuggets Championship Edition Mile High City Golden Ale
Breckenridge Brewery ("Breckenridge" or the "Brewery"), a pioneer in Colorado's craft beer scene, and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), announced today an exciting partnership with the Denver Nuggets to launch a...
Mar 28, 2024 08:00 ET
CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting
CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that three abstracts...
Mar 28, 2024 08:00 ET
Class Action Filed Against Fox Factory Holding Corp. (FOXF) - April 22, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / March 28, 2024 / If you suffered a loss on your Fox Factory Holding Corp. (NASDAQ:FOXF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 28, 2024 08:00 ET
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) reports financial results for the 12 months ended December 31, 2023, and provides updates on its antiviral product pipeline, upcoming milestones and business activities. “We are...
Mar 28, 2024 08:00 ET
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that Board Chair and co-founder George Goldsmith and fellow co-founder...
Mar 28, 2024 08:00 ET
CuraScientific Announces New Hydrogen Fuel Cell Product for 2025 - $200M Target Revenue for Residential Technology
via NewMediaWire – Today CuraScientific Corp. (the "Company") (OTCPINK: CSTF) is proud to announce its wholly-owned subsidiary, Sustainable Energy Group Inc., is developing a groundbreaking low-cost hydrogen fuel cell for residential solar...
Mar 28, 2024 08:00 ET
Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31, 2023 and provided a company update. “We are pleased with the incredible progress we made in 2023 with our...
Mar 28, 2024 08:00 ET
DRYWORLD Marches Into the Madness – Announces Partnership With Purdue Point Guard Braden Smith
DRYWORLD Brands Inc. (OTC: IBGR), a premium performance sports brand, is pleased to announce its partnership with Purdue University star point guard Braden Smith, through a one-year Name Image and Likeness (NIL) agreement making DRYWORLD his...
Mar 28, 2024 08:00 ET
Dynagas LNG Partners LP Reports Results for the Three Months and Year Ended December 31, 2023
Dynagas LNG Partners LP (NYSE: “DLNG”) (“the “Partnership”), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced its results for the three months and year ended December 31, 2023. Year Highlights:...
Mar 28, 2024 08:00 ET
Edgewise Therapeutics Announces Upcoming Podium Presentation at the American College of Cardiology's 2024 Annual Scientific Session
Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the Company will present data on EDG-7500 at the American College of Cardiology's Annual Scientific Session (ACC.24). EDG-7500 is a first-in-class oral, selective, cardiac sarcomere modulator, specifically designed to slow early contraction velocity and address impaired cardiac relaxation associated with HCM and other diseases of diastolic dysfunction. The conference will take place in Atlanta, GA at the Georgia World Congress Center from April 6-8, 2024.
Mar 28, 2024 08:00 ET
Enphase Energy Launches IQ8P Microinverters for High-Powered Solar Modules in Thailand and the Philippines
Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that it has started shipping IQ8P™ Microinverters, with peak output AC power...
Mar 28, 2024 08:00 ET
EpicQuest Education's Davis University Student Association Among World-Class Universities Including Ivy League Schools Invited to Attend the First International Student Congress in China
EEIQ's Successful Internationalization Strategy Leads to Davis University's Prominence Among the World's Elite Universities
Mar 28, 2024 08:00 ET
Essential Properties Realty Trust, Inc. to Report First Quarter 2024 Results on April 24, 2024
Essential Properties Realty Trust, Inc. (NYSE: EPRT; “Essential Properties” or the “Company”) announced today that the Company will release its operating results for the first quarter ended March 31, 2024, after the market close on Wednesday, April 24, 2024. The Company will host its first quarter 2024 earnings conference call and audio webcast on Thursday, April 25, 2024, at 10:00 a.m. Eastern Time to discuss its operating results.
Mar 28, 2024 08:00 ET
GCM Grosvenor Expands Credit Team with Two New Hires
GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, is pleased to announce the addition of Brandon Cahill and Scott Ingles to its established credit team. Cahill and Ingles' expertise and experience further...
Mar 28, 2024 08:00 ET
GoHealth to Present at Medicarians 2024: The Home of Senior Health, Wealth, and AgeTech
GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced the company will present at Medicarians 2024: The Home of Senior Health, Wealth, and AgeTech on Wednesday, April...
Mar 28, 2024 08:00 ET
Gorilla Technology Group to Introduce Security Solutions in Thailand’s Expanding Data Center Market
Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla"), a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence, and IoT technology, today announced its further expansion in the Thailand market, tackling...
Mar 28, 2024 08:00 ET
Gorilla Technology Group to Introduce Security Solutions in Thailand’s Expanding Data Center Market
Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla"), a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence, and IoT technology, today announced its further expansion in the Thailand market, tackling...
Mar 28, 2024 08:00 ET
Gorilla Technology Group to Present at the AI & Technology Hybrid Investor Conference presented by Water Tower Research on April 10 & 11
Gorilla Technology Group Inc. (“Gorilla”) (NASDAQ: GRRR), a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence, and IoT technology, today announced that Dr. Rajesh Natarajan, Chief Innovation Officer of...
Mar 28, 2024 08:00 ET
HarborOne Bancorp, Inc. Announces 6.7% Increase in First Quarter 2024 Dividend
HarborOne Bancorp, Inc. (the “Company”) (NASDAQ: HONE), the holding company of HarborOne Bank, today announced that its Board of Directors has declared a quarterly cash dividend of $0.08 per share, which represents an increase of $0.005 per share, or 6.7%, compared to its most recent dividend paid on January 18, 2024. The dividend will be paid on April 24, 2024 to all shareholders of record as of the close of business on April 10, 2024.
Mar 28, 2024 08:00 ET
Hut 8 Corp. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights - HUT
NEW YORK, NY / ACCESSWIRE / March 28, 2024 / If you suffered a loss on your Hut 8 Corp. (NASDAQ:HUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 28, 2024 08:00 ET
IMUNON Reports 2023 Financial Results and Provides Business Update
IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immuno-oncology therapies and next-generation vaccines, today reported financial results for the year ended December 31, 2023. The Company...
Mar 28, 2024 08:00 ET
Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference
Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, announces today that its CEO, Jeffrey Meckler will present a corporate overview at the...
Mar 28, 2024 08:00 ET
Integer Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024
Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 25, 2024. Following the release,...
Mar 28, 2024 08:00 ET
Iveda Finds 84% of Americans Are Concerned About Violence in The Country; Many Believe AI Could Help
Iveda® (NASDAQ:IVDA), the global solution for cloud-based AI, today released new data which shows that 84% of Americans are concerned about the rising rate of violence in the United States. In fact, the average American (79%) noted that they have changed their daily routine out of concern for their safety and wellbeing. Further, more than half (53%) of su

News Release Providers